Navigation Links
Effective Cure for Alcoholism – A single dose of LS
Post Your Comments:
(Date:5/15/2008)...service levels and expand prese...a, May 15 /PRNewswire/ -- Today, CoorsTek held a,g...ramics manufacturing,facility in South Korea. Sign...her specialty ceramics, primarily for the semicond...ies, fueled the additional facility., The grand o...
(Date:5/15/2008)...re Holdings, Inc. (the,"Company") today announced ...March 31, 2008., Net Revenues, Our net patient s... for,the three months ended March 31, 2008, to $88...eriod in 2007. Patient days in the 2008 period wer...2007., The increase in our net patient service re...
(Date:5/15/2008)...QLT Inc. (NASDAQ: QLTI; TSX:,QLT) announced today ...o,sell the land and building comprising its corpor...l of land in Vancouver, British Columbia.,Concurre...nter into a,five-year lease of space in the buildi...sed that our strategic efforts to divest non-core,...
(Date:5/15/2008)...Select Medical Corporation,("Select") today announ...2008., For the first quarter ended March 31, 2008... million compared to $466.8 million for the same,q...ed 9.9% to $54.3 million,compared to $60.3 million...eased 47.9% to $11.6 million compared to $22.2 mil...
Breaking Medicine News(10 mins):Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 2Health News:LifeCare Holdings, Inc. Announces First Quarter Results 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 4Health News:LifeCare Holdings, Inc. Announces First Quarter Results 5Health News:LifeCare Holdings, Inc. Announces First Quarter Results 6Health News:LifeCare Holdings, Inc. Announces First Quarter Results 7Health News:LifeCare Holdings, Inc. Announces First Quarter Results 8Health News:LifeCare Holdings, Inc. Announces First Quarter Results 9Health News:QLT Inc. announces agreement for sale of real estate 2Health News:QLT Inc. announces agreement for sale of real estate 3Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 2Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 3Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 4Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 5Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 6Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 7Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 8Health News:Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008 9
...hers have discovered that fatty acid ethyl esters ...portray the extent of fetal alcohol exposure//. "...n infant has been exposed to alcohol during pregna...y associated with alcohol use," said Enrique M. Os...
... holds immense promise for kids infected with Rota...for causing half a million deaths// amongst youngs...as also received the approval from the FDA for its...ections in children. A team of Researchers at the...
...ge Indian pharma companies and the needy patients ...ife-saving drugs, with global pharma giants like M...manding multi-billion annual sales. Domestic pha...oratories are being touted as major beneficiaries ...
...so far claimed at least 47 lives in Arunachal Prad...accounting for 27 deaths, official sources said. /...ths, R K Mission hospital sources reported 17 deat...orted from Kimin and Doimukh adjoining the state c...
Other Medicine News:
(Date:5/15/2008)...- Tigris Pharmaceuticals,Inc. announced today the...nt Agreement (CRADA) with the National Cancer Inst...ical development of AFP-464, an,aminoflavone curre...to,metabolites which bind covalently to DNA, resul...rt of a four-year CRADA encompassing multiple Phas...
(Date:5/15/2008)...ns Blue Cross Blue Shield of Michigan to Win ... HealthLeaders-InterStudy, NASHV...InterStudy, the,leading provider of managed care m...ntinues to stagnate in Michigan, Blue Cross Blue S... of its competitors to weather the,economic storm ...
(Date:5/15/2008)...of The American Society of Pediatric He...f., May 15 /- IDM Pharma, I... the presentation of updated data,from a compassio...PE) in,patients with lung metastases as a result o...n fatal bone tumor that typically affects,children...
(Date:5/14/2008)...all/ -- Biopure Corporation,(Nasdaq: BPUR ) today...nary,revascularization trial have been published i...paper is entitled "Proof-of-concept trial to,evalu...ive percutaneous,coronary revascularization. Ratio...The manuscript was authored by principal investiga...
Breaking Medicine Technology:Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 2Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 3Tri C to Celebrate Health Technologies Center Grand Opening April 4 14316 1Tri C to Celebrate Health Technologies Center Grand Opening April 4 14316 2Dr Ravi Nanda Joins OrthoSynetics 28TM 29 as Strategic Consultant 14314 1Dr Ravi Nanda Joins OrthoSynetics 28TM 29 as Strategic Consultant 14314 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 1516 1Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 1516 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 1516 3Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 1516 4Wellness Initiative for 2008 Tour de Georgia Presented by AT 26T Led by New Partnership With Blue Cross and Blue Shield of Georgia 14309 1Wellness Initiative for 2008 Tour de Georgia Presented by AT 26T Led by New Partnership With Blue Cross and Blue Shield of Georgia 14309 2Wellness Initiative for 2008 Tour de Georgia Presented by AT 26T Led by New Partnership With Blue Cross and Blue Shield of Georgia 14309 3Wellness Initiative for 2008 Tour de Georgia Presented by AT 26T Led by New Partnership With Blue Cross and Blue Shield of Georgia 14309 4
Product designed specifically for posteror segment surgical procedures. For dissection of vitreoretinal membrames using viscoelastic fluid. A high pressure luer lock tubing set is attached to cannula
Product designed specifically for posteror segment surgical procedures. Facilitates posterior segment infusion. Flexible tubing 10in (25cm).
For surgical treatment, repair and irrigation of the nasolacrimal system. Silicone tubing. Length 14in (35cm) ID: .012in (.30mm) OD: .025in (.60mm)
Replacment Tubing
Medicine Products: